🇺🇸 FDA
Pipeline program

Indomethacin and Ibuprofen

DMR94-IRB-13

Unknown small_molecule terminated

Quick answer

Indomethacin and Ibuprofen for Ductus Arteriosus, Patent is a Unknown program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Ductus Arteriosus, Patent
Phase
Unknown
Modality
small_molecule
Status
terminated

Clinical trials